Multiple Assemblies exist for SMTL entry 8g3e
Crystal structure of human WDR5 in complex with (1M)-N-[(3,5-difluoro[1,1'-biphenyl]-4-yl)methyl]-6-methyl-4-oxo-1-(pyridin-3-yl)-1,4-dihydropyridazine-3-carboxamide (compound 2, WDR5-MYC inhibitor); X-RAY DIFFRACTION 1.33 Å

	SMTL ID 8g3e.1 Ligands (1M)-N-[(3,5-difluoro[1,1'-biphenyl]-4-yl)methyl]-6-methyl-4-oxo-1-(pyridin-3-yl)-1,4-dihydropyridazine-3-carboxamide Polypeptides WD repeat-containing protein 5 Oligo-state monomer
	SMTL ID 8g3e.2 Ligands (1M)-N-[(3,5-difluoro[1,1'-biphenyl]-4-yl)methyl]-6-methyl-4-oxo-1-(pyridin-3-yl)-1,4-dihydropyridazine-3-carboxamide Polypeptides WD repeat-containing protein 5 Oligo-state monomer